Engineering therapeutics for the improved antitumor efficacy of chimeric antigen receptor T cell therapy 

Biochemical mechanism of TopBP1 recruitment to sites of DNA damage 

Microsoft Word - 4-Dissertation_Shanxi Feng.doc 

Kinase activity of the pseudohypoaldosteronism type II gene product, WNK4 

Investigating the E. Coli DNA polymerase V mutasome 

etd-LinAnderso-464.pdf 

Detection of anti-Hu antibodies, a possible key to early diagnosis of small cell lung cancer 

Characterization of the role of LIM and SH3 protein (LASP-1) in endocytosis and actin cytoskeleton remodeling 

The mechanism of damage-induced mutations in Escherichia coli 

Stefanie Marquez 

Microsoft Word - $ASQ116369_supp_undefined_7757EFF4-F5CE-11E0-B683-4781F0E6BF1D.doc 

Role of Notch and hyaluronan in modulating the expression of lymphatic vessel endothelial hyaluronan receptor1 (LYVE1) 

etd-ChangHsiao-368.pdf 

Imaging and prodrug -activating derivatives of chTNT-3 (tumor necrosis therapy) monoclonal antibody 

Novel design and combinatory therapy to enhance chimeric antigen receptor engineered T cells (CAR-T) efficacy against solid tumor 

Development of metabolic chemical reporters for the investigation of protein glycosylation 

Decrypting Escherichia coli DNA polymerase V mutasome ATP regulation 

Developing and characterizing a genetically encoded probe to the presynaptic active zone protein RIM1α 

Mechanism of human nonhomologous DNA end joining 

Atomic force microscopy applications in sensing and actuation 

Customization of the mRNA display cycle – from protease resistance to high throughput analysis of peptide ligands 

Biochemistry of nonhomologous DNA end joining (NHEJ) and its role in V(D)J recombination 

Optimization of genetically engineered monoclonal antibody and antibody /cytokine fusion proteins for the detection and immunotherapy of solid malignancies 

Toward a new (Au)ra of gold-based therapeutics: thio-reactive probes in autoimmunity 

Biochemistry and reconstitution of V(D)J recombination in a purified system